The role of PTEN and TP53 co-mutations in immunotherapy of lung cancer.

e21161Background: Patients with non-small cell lung cancer (NSCLC) harboring PTEN mutations have a worse prognosis of immunotherapy in research with small sample size and case reports. However, the...